[
    "{\"step_by_step_thinking\": \"Istiratumab is an experimental monoclonal antibody for the treatment of cancer, including pancreatic cancer, as mentioned in Document [0]. However, according to Document [1], a study found that istiratumab failed to improve the efficacy of standard of care chemotherapy in patients with metastatic pancreatic cancer. Therefore, based on the available documents, it seems that istiratumab is not effective for pancreatic cancer.\", \"answer_choice\": \"B. no\"}"
]